Monday, 28 September 2026Updated 11m ago
← Top stories
● Neutral for Zydus Lifesciences

Zydus Life USFDA inspection at Ahmedabad plant concludes with 1 observation

1 source · first seen 19:00 28 Sept · updated 19:00 28 Sept

The brief

Written from 1 report · check the source before you trade
  • The Ahmedabad plant inspection concluded with one observation; Zydus said there were no data integrity-related observations
  • Zydus said it will work closely with the USFDA
  • The inspection outcome matters to Zydus Lifesciences’ regulated-market business

Tags on this story

Pick a tag to see all its stories
Zydus Lifesciences₹1,215.00 · 4 todayUSFDA5 todayPharma and healthcare30 today

Linked by the tag Zydus Lifesciences

7 stories this week
  1. 25 SeptIndian stock market slides, but 28 Nifty 500 stocks hit fresh 1-year highs this week; MCX, PVR Inox among themMarket move · 1 source · Nifty 50 fell 0.88% over the week, its biggest decline since 2020
All Zydus Lifesciences stories →

Read the reports

1 report · earliest 19:00
CNBC-TV18Zydus Life USFDA inspection at Ahmedabad plant concludes with 1 observation19:00